Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aprepitant for delayed emesis in breast cancer
NCT00869973Phase 3Terminated
- Sponsor
- Hospital de Santa Maria
- Start
- Sep 2009
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of aprepitant in chemotherapy-induced nausea and vomiting (CINV), sponsored by Hospital de Santa Maria. Primary endpoint: Complete Response. Started Sep 2009; status: terminated.
02
Drugs
aprepitant
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT00869973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00869973.